Results 181 to 190 of about 96,485 (242)
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. [PDF]
Alexis A +16 more
europepmc +1 more source
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study. [PDF]
Trovato E +30 more
europepmc +1 more source
Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors. [PDF]
Medjedovic L +6 more
europepmc +1 more source
Efficacy of Flaxseed Oil in Treating Mild to Moderate Psoriasis Vulgaris Compared with Topical Betamethasone: A Randomized, Double-Blind, Clinical Trial. [PDF]
Mohammadian Rasanan F +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI
Australasian Journal of Dermatology, 2021AbstractThis comparative observational study aimed to validate an online Patient‐oriented Psoriasis Area and Severity Index (PO‐PASI) by comparing it against the Psoriasis Area and Severity Index (PASI), of 97 adult participants with chronic plaque psoriasis.
Abraham Montes de Oca Pedrosa +3 more
openaire +2 more sources

